Subclinical hepatic encephalopathy impairs daily functioning

被引:383
作者
Groeneweg, M
Quero, JC
De Bruijn, I
Hartmann, IJC
Essink-bot, ML
Hop, WCJ
Schalm, SW
机构
[1] Erasmus Univ Hosp, Dept Hepatogastroenterol, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus Univ Hosp, Dept Publ Hlth, NL-3015 GD Rotterdam, Netherlands
[3] Erasmus Univ Hosp, Dept Biostat, NL-3015 GD Rotterdam, Netherlands
关键词
D O I
10.1002/hep.510280108
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Subclinical hepatic encephalopathy (SHE) is assumed to have a negative effect on patients' daily functioning; therefore, treatment is recommended. However, no studies have been performed that document the clinical relevance of SHE, We performed a study in which the prevalence of SHE was determined in 179 outpatients with cirrhosis using two psychometric tests (Number Connection Test Part A [NCT-A] and the Digit Symbol Test [DGT]) and automated analysis of the electroencephalogram (EEG). !,HE was defined by the presence of at least one abnormal psychometric test and/or abnormal slowing of the EEG, The influence of cirrhosis and SHE on patients' daily functioning was assessed using the Sickness Impact Profile (SIP) questionnaire. The distribution of SIP scores of the patients with cirrhosis differed from the reference scores of the general population. Patients with cirrhosis and SHE (n = 48) reported significantly more impairment in all 12 scales of the SIP, in the psychosocial subscore, the physical subscore, as well as in the total SIP score, compared with cirrhotic patients without SHE (n = 131). Multivariate analysis taking into account severity of liver disease (Child-Pugh score), presence of varices, and alcoholic etiology, showed that SHE independently was related to a diminished total SIP score. The reproducibility of the SIP was high when the test was repeated after a 3-month period. We conclude that SHE implies impaired daily functioning and warrants attempts at treatment.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 44 条
[1]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[2]   ESTIMATING THE RELIABILITY OF CONTINUOUS MEASURES WITH CRONBACH ALPHA OR THE INTRACLASS CORRELATION-COEFFICIENT - TOWARD THE INTEGRATION OF 2 TRADITIONS [J].
BRAVO, G ;
POTVIN, L .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (4-5) :381-390
[3]   PATHOGENESIS AND TREATMENT OF PORTAL SYSTEMIC ENCEPHALOPATHY - AN UPDATE [J].
BUTTERWORTH, RF .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (03) :321-327
[4]  
CONN EO, 1994, HEPATIC ENCEPHALOPAT, P1
[5]  
DAVIS GL, 1994, CLIN THER, V16, P334
[6]  
de Melker R A, 1990, Ned Tijdschr Geneeskd, V134, P946
[7]   BRANCHED-CHAIN AMINO-ACIDS IN THE TREATMENT OF LATENT PORTOSYSTEMIC ENCEPHALOPATHY - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY [J].
EGBERTS, EH ;
SCHOMERUS, H ;
HAMSTER, W ;
JURGENS, P .
GASTROENTEROLOGY, 1985, 88 (04) :887-895
[8]   NHP or SIP - A comparative study in renal insufficiency associated anemia [J].
EssinkBot, ML ;
Krabbe, PFM ;
vanAgt, HME ;
Bonsal, GJ .
QUALITY OF LIFE RESEARCH, 1996, 5 (01) :91-100
[9]   PSYCHOMOTOR PERFORMANCE DEFECTS IN CIRRHOTIC-PATIENTS WITHOUT OVERT ENCEPHALOPATHY [J].
GILBERSTADT, SJ ;
GILBERSTADT, H ;
ZIEVE, L ;
BUEGEL, B ;
COLLIER, RO ;
MCCLAIN, CJ .
ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (04) :519-521
[10]   THE DIAGNOSIS AND PREVALENCE OF SUBCLINICAL HEPATIC-ENCEPHALOPATHY IN APPARENTLY HEALTHY, AMBULANT, NON-SHUNTED PATIENTS WITH CIRRHOSIS [J].
GITLIN, N ;
LEWIS, DC ;
HINKLEY, L .
JOURNAL OF HEPATOLOGY, 1986, 3 (01) :75-82